S100A7 and neoplasm: With tumor progression, S100A7 translocates into the nucleus, where the psoriasin—Jab1 complex transactivates tumor-promoting AP-1 targets and oncogenic COP9 signalosome signaling, while loses the cytoplasmic function as a negative regulator of β-catenin mediated oncogenic c-Myc activity.